Literature DB >> 27473091

Recommend, but also Discuss: Different Patterns of Physician-Perceived Barriers to Discussing HPV Vaccination and Their Association with Vaccine Administration in 11-12 Year-Old Girls.

Andrzej Kulczycki1, Haiyan Qu2, Richard Shewchuk2.   

Abstract

Objectives We examined variation in primary care physicians' (PCPs') perceptions of barriers to physician-initiated discussion of HPV vaccination, and how this is associated with the rates at which they discuss, initiate and continue to administer vaccination with 11-12 year-old girls. Methods We surveyed 301 PCPs using systematic random sampling. PCP variation in perceived barriers to discussing HPV vaccination was modeled using latent class analysis (LCA). The distinct PCP groups identified were compared with each other using three iterative logistic regression models to predict the likelihood of initiating vaccine discussion and the reported percentages of 11-12 year-old patients who initiated HPV vaccination and received follow-up shots. Results LCA revealed three groups of PCPs who perceived major, moderately significant and relatively minor barriers (17.9, 41.9 and 40.2 % of respondents, respectively). Pediatricians, PCPs who were female, had minority racial/ethnic status and who perceived only minor barriers had significantly higher odds of initiating discussion. PCPs were more likely to initiate HPV vaccination if they had initiated discussion and perceived minor or moderate communication barriers. Increased likelihood to administer follow-up HPV vaccine was associated with having initiated discussion, perceiving only minor barriers and working outside Deep South states, but not with having initiated vaccination. Conclusions for Practice PCPs who discuss HPV vaccination with girls aged 11-12 and their mothers are more likely to start and sustain vaccine administration. However, different PCPs perceive barriers to discussion in different ways. Interventions tailored to different groups of PCPs should assist them in overcoming barriers to discussing their recommendations when necessary.

Entities:  

Keywords:  Barriers; Follow-up vaccination; HPV vaccine; Human papillomavirus (HPV); Physician-initiated discussion; Primary care physician; Vaccine initiation

Mesh:

Substances:

Year:  2016        PMID: 27473091     DOI: 10.1007/s10995-016-2079-9

Source DB:  PubMed          Journal:  Matern Child Health J        ISSN: 1092-7875


  26 in total

Review 1.  Why don't physicians follow clinical practice guidelines? A framework for improvement.

Authors:  M D Cabana; C S Rand; N R Powe; A W Wu; M H Wilson; P A Abboud; H R Rubin
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

2.  Vaccine counseling: a content analysis of patient-physician discussions regarding human papilloma virus vaccine.

Authors:  Sarah L Goff; Kathleen M Mazor; Shawn J Gagne; Kristin C Corey; Diane R Blake
Journal:  Vaccine       Date:  2011-08-10       Impact factor: 3.641

3.  Reasons for not vaccinating adolescents: National Immunization Survey of Teens, 2008-2010.

Authors:  Paul M Darden; David M Thompson; James R Roberts; Jessica J Hale; Charlene Pope; Monique Naifeh; Robert M Jacobson
Journal:  Pediatrics       Date:  2013-03-18       Impact factor: 7.124

4.  Frictions as barriers to perioperative alignment: results from a latent class analysis.

Authors:  Richard M Shewchuk; Greg L Carlson; Matt Klosterman; Stephen Cullen; Haiyan Qu
Journal:  Qual Manag Health Care       Date:  2014 Jul-Sep       Impact factor: 0.926

5.  Correlates of human papillomavirus vaccine coverage: a state-level analysis.

Authors:  Jennifer L Moss; Paul L Reiter; Noel T Brewer
Journal:  Sex Transm Dis       Date:  2015-02       Impact factor: 2.830

6.  Physicians' human papillomavirus vaccine recommendations, 2009 and 2011.

Authors:  Susan T Vadaparampil; Teri L Malo; Jessica A Kahn; Daniel A Salmon; Ji-Hyun Lee; Gwendolyn P Quinn; Richard G Roetzheim; Karen L Bruder; Tina M Proveaux; Xiuhua Zhao; Neal A Halsey; Anna R Giuliano
Journal:  Am J Prev Med       Date:  2014-01       Impact factor: 5.043

7.  Examining the diverse perspectives of nurse practitioners regarding obstacles to diaphragm prescription: a latent class analysis.

Authors:  Andrzej Kulczycki; Haiyan Qu; Penelope M Bosarge; Richard M Shewchuk
Journal:  J Womens Health (Larchmt)       Date:  2010-07       Impact factor: 2.681

Review 8.  Communicating evidence for participatory decision making.

Authors:  Ronald M Epstein; Brian S Alper; Timothy E Quill
Journal:  JAMA       Date:  2004-05-19       Impact factor: 56.272

9.  Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.

Authors:  Emiko Petrosky; Joseph A Bocchini; Susan Hariri; Harrell Chesson; C Robinette Curtis; Mona Saraiya; Elizabeth R Unger; Lauri E Markowitz
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-03-27       Impact factor: 17.586

10.  National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years--United States, 2014.

Authors:  Sarah Reagan-Steiner; David Yankey; Jenny Jeyarajah; Laurie D Elam-Evans; James A Singleton; C Robinette Curtis; Jessica MacNeil; Lauri E Markowitz; Shannon Stokley
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-07-31       Impact factor: 17.586

View more
  3 in total

1.  Relative contributions of parental intention and provider recommendation style to HPV and meningococcal vaccine receipt.

Authors:  Terresa J Eun; Amresh Hanchate; Anny T Fenton; Jack A Clark; Marisa N Aurora; Mari-Lynn Drainoni; Rebecca B Perkins
Journal:  Hum Vaccin Immunother       Date:  2019-04-16       Impact factor: 3.452

Review 2.  Recommendations and barriers to vaccination in systemic lupus erythematosus.

Authors:  Megha Garg; Naaima Mufti; Tara N Palmore; Sarfaraz A Hasni
Journal:  Autoimmun Rev       Date:  2018-08-11       Impact factor: 9.754

3.  Primary care pediatricians' attitudes and practice towards HPV vaccination: A nationwide survey in Italy.

Authors:  Francesco Napolitano; Monica Navaro; Luigi Vezzosi; Gabriella Santagati; Italo Francesco Angelillo
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.